Alpha Real Trust (ARTL) Share Price, News & Analysis

Company Overview

Alpha Real Trust Limited specializes in investments in securities, services, and other related businesses. The fund seeks to invest in the United Kingdom and Europe.

Key Stats

• Today's Range: 190 to 200
• 50-Day Range: 108.10 to 200
• 52-Week Range: 108 to 205
• Volume: 42,307 shs
• Average Volume: 9,601 shs
• Market Capitalization: £120.56 million
• P/E Ratio: N/A
• Dividend Yield: 2.00%
• Price Target: N/A
• Consensus Rating: N/A

ARTL Stock Analysis - Frequently Asked Questions

How have ARTL shares performed this year?

Alpha Real Trust's stock was trading at GBX 118 at the beginning of 2024. Since then, ARTL shares have increased by 69.5% and is now trading at GBX 200.
View the best growth stocks for 2024 here.

How do I buy shares of Alpha Real Trust?

Shares of ARTL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Alpha Real Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Alpha Real Trust investors own include AIkido Pharma (AIKI), AMC Entertainment (AMC), Advanced Micro Devices (AMD), A10 Networks (ATEN), Skillz (SKLZ), Tilray (TLRY) and Aurora Cannabis (ACB).

Company Calendar

• Ex-Dividend for 10/25 Dividend: 9/26/2024
• Dividend Payable: 10/25/2024
• Ex-Dividend for 1/24 Dividend: 12/05/2024
• Today: 12/22/2024
• Dividend Payable: 1/24/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: Pharmaceutical Products
• Current Symbol: LON:ARTL
• CUSIP: N/A
• CIK: N/A
• Web: www.alpharealtrustlimited.com
• Phone: +44-20-75911615
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £1.28 million
• Net Margins: -10.07%
• Pretax Margin: N/A
• Return on Equity: -0.75%
• Return on Assets: 1.74%

Debt

• Debt-to-Equity Ratio: 6.57
• Current Ratio: 62.73
• Quick Ratio: 31.39

Sales & Book Value

• Annual Sales: £9.23 million
• Price / Sales: 13.06
• Cash Flow: GBX 115.05 per share
• Price / Cash Flow: 1.74
• Book Value: GBX 207 per share
• Price / Book: 0.97

Miscellaneous

• Outstanding Shares: 60,280,000
• Free Float: N/A
• Market Cap: £120.56 million
• Optionable: Not Optionable
• Beta: 0.28